Electrochemiluminescence Lateral Flow Immunoassay Using Ruthenium(II) Complex‐Loaded Dendritic Mesoporous Silica Nanospheres for Highly Sensitive and Quantitative Detection of SARS‐CoV‐2 Nucleocapsid Protein
Advanced Functional Materials · 2024-12 · 34 (51)
DOI: 10.1002/adfm.202409632 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 05.08.2024. Verfasst von Wenxuan Fu und 6 weiteren Autor:innen. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Lateral flow immunoassays (LFIA) are widely used for the cost‐effective and rapid detection of diverse analytes. However, traditional LFIA suffers from difficulties in providing quantitative results and has low sensitivity. Herein, LFIA is combined with electrochemiluminescence (ECL), a leading transduction technique with high sensitivity and wide dynamic range, to achieve highly sensitive and quantitative detection of severe acute respiratory syndrome coronavirus nucleocapsid protein (SARS‐CoV‐2 N protein). Ruthenium(II)‐based complexes are synthesized and loaded into dendritic mesoporous silica nanospheres (PEI‐Ru/dSiO 2 ), which possessed central‐radial pore channels and served as tags for ECL‐LFIA. The electrodes are fabricated on a nitrocellulose (NC) membrane, which simplifies the structure of the ECL‐LFIA. PEI‐Ru/dSiO 2 is captured on the electrode surface via a sandwich immunoreaction, which enhances the ECL signal by decreasing the distance between PEI‐Ru/dSiO 2 and the electrode surface. Using 2,2‐bis(hydroxymethyl)‐2,2′,2′'‐nitrilotriethanol (BIS‐TRIS) as coreactant, the ECL‐LFIA is used for detecting SARS‐CoV‐2 N protein, with a linear range of 1–10 4 ng mL −1 and a limit of detection (LOD) of 0.52 ng mL −1 . ECL‐LFIA can also be used to detect analytes in complex matrices. These results demonstrate that the prepared ECL‐LFIA has great potential as a point‐of‐care testing platform for the rapid and quantitative detection of disease biomarkers.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Fu, W., Wang, X., Ying, X., Sun, T., Wang, Y., Wang, J., & Su, B. (2024). Electrochemiluminescence Lateral Flow Immunoassay Using Ruthenium(II) Complex‐Loaded Dendritic Mesoporous Silica Nanospheres for Highly Sensitive and Quantitative Detection of SARS‐CoV‐2 Nucleocapsid Protein. Advanced Functional Materials, 34(51). https://doi.org/10.1002/adfm.202409632
Vancouver
Fu W, Wang X, Ying X, Sun T, Wang Y, Wang J, et al. Electrochemiluminescence Lateral Flow Immunoassay Using Ruthenium(II) Complex‐Loaded Dendritic Mesoporous Silica Nanospheres for Highly Sensitive and Quantitative Detection of SARS‐CoV‐2 Nucleocapsid Protein. Advanced Functional Materials. 2024;34(51). doi:10.1002/adfm.202409632
BibTeX
@article{Fu2024,
author = {Fu, Wenxuan and Wang, Xuexue and Ying, Xudong and Sun, Tao and Wang, Yafeng and Wang, Jing and Su, Bin},
title = {Electrochemiluminescence Lateral Flow Immunoassay Using Ruthenium(II) Complex‐Loaded Dendritic Mesoporous Silica Nanospheres for Highly Sensitive and Quantitative Detection of SARS‐CoV‐2 Nucleocapsid Protein},
journal = {Advanced Functional Materials},
year = {2024},
volume = {34},
number = {51},
doi = {10.1002/adfm.202409632}
}
EUVIMED